Full-Time

Senior Data Scientist

Proteomics

Updated on 11/26/2024

Calico Labs

Calico Labs

201-500 employees

Research and develop treatments for aging

Biotechnology
Healthcare

Compensation Overview

$120k - $172kAnnually

+ Annual Cash Bonuses

Senior, Expert

San Bruno, CA, USA

Must work onsite at least four days a week.

Category
Bioinformatics
Data Science
Biology & Biotech
Data & Analytics
Required Skills
Python
Data Science
R
Data Structures & Algorithms
Data Analysis
Requirements
  • Masters degree or Ph.D. in a quantitative discipline such as statistics, biostatistics, computer science, bioinformatics, or computational biology
  • Expertise in statistical data analysis
  • Experience working with proteomics data and proteomics software (e.g., Sequest, Byonic, PD, MaxQuant, PEAKS, etc.)
  • Fluent coding skills in one or more programming languages (preferably R and/or python). Basic familiarity with the R programming language is strongly preferred.
  • Outstanding communication and collaborative worth ethic
  • Intellectual curiosity, attention to detail, and good follow-through
  • Proactive approach to collaborations and a demonstrated ability to work in a team environment
  • Must be willing to work onsite currently at least four days a week
Responsibilities
  • Develop data analysis strategies, write algorithms, and help with the analysis of proteomics data, in particular data from large patient cohorts and non-standard proteome profiling experiments
  • Maintain and continue to develop in-house developed proteomics algorithms and software tools
  • Explore and deploy external algorithms, software, and tools as needed to complement in-house software
  • Work with software engineers, data scientists, the proteomics team, and scientists at Calico to develop novel platforms for extracting biological insight from experimental data at multiple spatial and temporal scales
  • Interact closely with scientists in the proteomics team, basic research, and in drug development to understand their data analysis needs and provide answers to technical questions through custom analyses, 1-on-1 communication, presentations, and written documents

Calico Labs focuses on researching the biology of aging and creating treatments for age-related diseases. The company conducts scientific research to understand how aging works and the diseases that come with it. By collaborating with academic institutions and other biopharmaceutical companies, Calico Labs uses advanced technologies to drive research and develop practical medical solutions. This collaborative approach helps speed up research and increases the chances of making important discoveries in aging. Calico Labs earns revenue through partnerships, joint research projects, and potential licensing of its technologies. The main goal is to contribute significantly to the understanding and treatment of aging.

Company Stage

Seed

Total Funding

$2M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • The inclusion of fosigotifator in the FDA's START Pilot Program highlights Calico Labs' potential to develop groundbreaking treatments for rare diseases.
  • Extending the collaboration with the Broad Institute until 2029 ensures continued progress in understanding aging and developing therapies for age-related neurodegeneration.
  • The appointment of renowned experts like Michael Lenardo, M.D., as Chief Scientific Officer strengthens Calico Labs' leadership and scientific expertise.

What critics are saying

  • The highly specialized focus on aging and age-related diseases may limit the company's market opportunities compared to broader biopharmaceutical firms.
  • Dependence on strategic partnerships and collaborations could pose risks if these alliances face challenges or dissolve.

What makes Calico Labs unique

  • Calico Labs focuses exclusively on the biology of aging and age-related diseases, setting it apart from other biopharmaceutical companies with broader research scopes.
  • Their strategic partnerships with leading academic institutions and biopharmaceutical firms, such as the Broad Institute and AbbVie, enhance their research capabilities and accelerate innovation.
  • Calico Labs' emphasis on interdisciplinary collaboration and advanced technologies fosters a unique research environment that drives significant scientific discoveries.

Help us improve and share your feedback! Did you find this helpful?